Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
Clinical trial NCT05113368 · RECRUITING
Trial details
- NCT number
- NCT05113368
- Sponsor
- Sarah K. Lynam MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-28
- Primary completion
- 2026-09-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.